Literature DB >> 22754198

C-reactive protein and uric Acid levels in patients with psoriasis.

V K Jain, Harbans Lal.   

Abstract

Serum CRP and uric acid levels were estimated in twenty-five patients with psoriasis (group III) before and after 12 weeks of treatment. Results were compared with a group of 25 normal subjects (group I) and a group of 25 patients of various skin diseases other than psoriatic lesion (group II). Mean value for CRP was found to be increased by more than 20 folds in patients with psoriasis, which was subsequently reduced to nearly 50% of the initial value after 12 weeks of treatment. These patients also showed hyperuricemia. Nearly 25% of these patients also exhibited arthritis. It is thus suggested that both CRP and uric acid levels should be monitored in patients with psoriasis.

Entities:  

Keywords:  CRP; Psoriasis; Uric acid

Year:  2011        PMID: 22754198      PMCID: PMC3162954          DOI: 10.1007/s12291-011-0132-4

Source DB:  PubMed          Journal:  Indian J Clin Biochem        ISSN: 0970-1915


  8 in total

Review 1.  C-reactive protein: a critical update.

Authors:  Mark B Pepys; Gideon M Hirschfield
Journal:  J Clin Invest       Date:  2003-06       Impact factor: 14.808

2.  Manual and automated methods for measuring urea based on a modification of its reaction with diacetyl monoxime and thiosemicarbazide.

Authors:  R T Evans
Journal:  J Clin Pathol       Date:  1968-07       Impact factor: 3.411

3.  C-reactive protein and the risk of developing hypertension.

Authors:  Howard D Sesso; Julie E Buring; Nader Rifai; Gavin J Blake; J Michael Gaziano; Paul M Ridker
Journal:  JAMA       Date:  2003-12-10       Impact factor: 56.272

4.  The inflammatory response in mild and in severe psoriasis.

Authors:  P Rocha-Pereira; A Santos-Silva; I Rebelo; A Figueiredo; A Quintanilha; F Teixeira
Journal:  Br J Dermatol       Date:  2004-05       Impact factor: 9.302

5.  Usefulness of combining serum uric acid and C-reactive protein for risk stratification of patients with coronary artery disease (Bezafibrate Infarction Prevention [BIP] study).

Authors:  Yafim Brodov; Shlomo Behar; Ilan Goldenberg; Valentina Boyko; Pierre Chouraqui
Journal:  Am J Cardiol       Date:  2009-05-04       Impact factor: 2.778

6.  Effects of etanercept on C-reactive protein levels in psoriasis and psoriatic arthritis.

Authors:  B Strober; C Teller; P Yamauchi; J L Miller; M Hooper; Y-C Yang; F Dann
Journal:  Br J Dermatol       Date:  2008-05-22       Impact factor: 9.302

7.  Purine-rich foods, dairy and protein intake, and the risk of gout in men.

Authors:  Hyon K Choi; Karen Atkinson; Elizabeth W Karlson; Walter Willett; Gary Curhan
Journal:  N Engl J Med       Date:  2004-03-11       Impact factor: 91.245

8.  Serum levels of C-reactive protein and uric acid in patients with cardiac syndrome X.

Authors:  Serpil Eroglu; Leyla Elif Sade; Aylin Yildirir; Ozlem Demir; Huseyin Bozbas; Haldun Muderrisoglu
Journal:  Acta Cardiol       Date:  2009-04       Impact factor: 1.718

  8 in total
  16 in total

1.  Psoriasis, psoriatic arthritis and risk of gout in US men and women.

Authors:  Joseph F Merola; Shaowei Wu; Jiali Han; Hyon K Choi; Abrar A Qureshi
Journal:  Ann Rheum Dis       Date:  2014-03-20       Impact factor: 19.103

2.  Chronic tophaceous gout in patients with psoriasis.

Authors:  Laís Cruz Lobato; Jéssica Castiel Coutinho; Maria Zeli Moreira Frota; Antonio Pedro Mendes Schettini; Mônica Santos
Journal:  An Bras Dermatol       Date:  2017 Jan-Feb       Impact factor: 1.896

3.  Evaluation of Anti-Cyclic Citrullinated Peptide Autoantibodies and C-Reactive Protein in Common Autoimmune Skin Diseases with and without Arthritis.

Authors:  Bandana Kumari; Pawan Kumar; Radha Krishna Prasad Chaudhary
Journal:  J Clin Diagn Res       Date:  2017-07-01

Review 4.  Association of Serum Uric Acid Levels in Psoriasis: A Systematic Review and Meta-Analysis.

Authors:  Xin Li; Xiao Miao; Hongshen Wang; Yifei Wang; Fulun Li; Qiong Yang; Rutao Cui; Bin Li
Journal:  Medicine (Baltimore)       Date:  2016-05       Impact factor: 1.889

5.  Atorvastatin as an adjuvant with betamethasone valerate reduces disease severity and cardiovascular risks in Psoriasis.

Authors:  Farah Asad; Moosa Khan; Fatima Rizvi
Journal:  Pak J Med Sci       Date:  2017 Nov-Dec       Impact factor: 1.088

6.  C-reactive protein serum level in patients with psoriasis before and after treatment with narrow-band ultraviolet B.

Authors:  Mahmoud Farshchian; Akram Ansar; Mohammadreza Sobhan; Valiollah Hoseinpoor
Journal:  An Bras Dermatol       Date:  2016 Sep-Oct       Impact factor: 1.896

7.  The effect of subcutaneous methotrexate on markers of metabolic syndrome in psoriatic patients - preliminary report.

Authors:  Agnieszka Owczarczyk-Saczonek; Marek Drozdowski; Agata Maciejewska-Radomska; Dariusz Choszcz; Waldemar Placek
Journal:  Postepy Dermatol Alergol       Date:  2018-02-20       Impact factor: 1.837

8.  Updated Evidence of the Association Between Elevated Serum Uric Acid Level and Psoriasis.

Authors:  Ying Zhang; Liu Liu; Xiaoying Sun; Hongjin Li; Yifei Wang; Min Zhou; Liang Hua; Bin Li; Xin Li
Journal:  Front Med (Lausanne)       Date:  2021-06-29

9.  Serum levels of hypersensitive-C-reactive protein in moderate and severe acne.

Authors:  M R Namazi; A R Parhizkar; F Jowkar
Journal:  Indian Dermatol Online J       Date:  2015 Jul-Aug

10.  Assessment of lipocalin 2, clusterin, soluble tumor necrosis factor receptor-1, interleukin-6, homocysteine, and uric acid levels in patients with psoriasis.

Authors:  Arzu Ataseven; Recep Kesli; Gulcan Saylam Kurtipek; Perihan Ozturk
Journal:  Dis Markers       Date:  2014-04-02       Impact factor: 3.434

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.